ChiCTR2000038820 版本V1.0 版本创建时间2020/10/04 23:53:08 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000038820 

最近更新日期:

Date of Last Refreshed on:

2020-10-04 23:53:04 

注册时间:

Date of Registration:

2020-10-04 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

ERAS操联合保护性肺通气策略在结直肠老年手术患者中的前瞻性随机对照临床研究

Public title:

The utilization of ERAS exercises combined with protective ventilation strategy and its effect on elder patients undergoing colorectal surgery---a prospective randomized controlled trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

ERAS操联合保护性肺通气策略在结直肠老年手术患者中的前瞻性随机对照临床研究

Scientific title:

The utilization of ERAS exercises combined with protective ventilation strategy and its effect on elder patients undergoing colorectal surgery---a prospective randomized controlled trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

闵苏 

研究负责人:

陈婧 

Applicant:

MIN SU 

Study leader:

CHEN JING 

申请注册联系人电话:

Applicant telephone:

13042356895

研究负责人电话:

Study leader's telephone:

13883037384

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

377535247@qq.com

研究负责人电子邮件:

Study leader's E-mail:

56410019@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区袁家岗友谊路1号

研究负责人通讯地址:

重庆市渝中区袁家岗友谊路1号

Applicant address:

#1 Youyi Road, Yuzhong District, Chongqing Municipality

Study leader's address:

重庆市渝中区袁家岗友谊路1号

申请注册联系人邮政编码:

Applicant postcode:

400016

研究负责人邮政编码:

Study leader's postcode:

400016

申请人所在单位:

重庆医科大学附属第一医院

Applicant's institution:

The first affiliated hospital of Chongqing Medical University

研究负责人所在单位:

重庆医科大学附属第一医院

Affiliation of the Leader:

The first affiliated hospital of Chongqing Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020-06

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属第一医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2020-06-22 00:00:00

伦理委员会联系人:

罗天友

Contact Name of the ethic committee:

LUO TIIANYOU

伦理委员会联系地址:

重庆医科大学附属第一医院

Contact Address of the ethic committee:

The first affiliated hospital of Chongqing Medical University

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

重庆医科大学附属第一医院

Primary sponsor:

The first affiliated hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

重庆市渝中区袁家岗友谊路1号

Primary sponsor's address:

#1 Youyi Road, Yuzhong District, Chongqing Municipality

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

渝中区

Country:

China

Province:

Chongqing

City:

Yuzhong District

单位(医院):

重庆医科大学附属第一医院

具体地址:

袁家岗友谊路1号

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Address:

1 Youyi Road

经费或物资来源:

自筹

Source(s) of funding:

Self-funding

Target disease:

postoperative complications of elder patients undergoing colorectal surgery

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.明确ERAS操的术前规范训练对行结直肠手术的老年患者术后肺部并发症的影响 2.建立年龄、术前合并症、手术方式等因素影响术后肺部并发症的临床风险预测模型  

Objectives of Study:

1.To clarify the influence of preoperative normative training of ERAS exercises on pulmonary complications after colorectal surgery in elderly patients. 2.To establish a clinical risk prediction model for postoperative pulmonary complications affected by factors such as age, preoperative complications and surgical mode.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

65 ≤年龄 ≤80岁;行择期腹腔镜下结、直肠手术的全身麻醉患者;ASA分级Ⅰ-Ⅲ级;体重指数18~25kg/m2.

Inclusion criteria

65-80 years old;Colorectal surgical patients;ASA I-III stage;BMI 18-25kg/m2.

排除标准:

体重指数<18kg/m2、>25kg/m2;手术操作涉及盆腹腔其他脏器(肝脏、肾脏、胰腺、子宫、脾脏、胃);心跳骤停;患精神性疾病且不能正确表达意愿者;妊娠.

Exclusion criteria:

BMI<18 or >25kg/m2;Operation involves other organs in the pelvic cavity;Intraoperative cardiopulmonary arrest or death
Psychological diseases, pregnancy.

研究实施时间:

Study execute time:

From 2020-12-01 00:00:00 To 2022-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-12-15 00:00:00 To 2022-08-01 00:00:00  

干预措施:

Interventions:

组别:

ERAS操组

样本量:

80

Group:

ERAS exercise group

Sample size:

干预措施:

ERAS操术前训练

干预措施代码:

Intervention:

preoperative training of ERAS exercise

Intervention code:

组别:

对照组

样本量:

80

Group:

Controlled group

Sample size:

干预措施:

无术前训练

干预措施代码:

Intervention:

no ERAS exercise before surgery

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

渝中区 

Country:

China 

Province:

Chongqing 

City:

Yuzhong District 

单位(医院):

重庆医科大学附属第一医院 

单位级别:

三级 

Institution
hospital:

The First Affiliated Hospital of Chongqing Medical University

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

术后肺部并发症

指标类型:

主要指标

Outcome:

postoperative pulmonary complication

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后30天死亡率

指标类型:

主要指标

Outcome:

Mortality rate within 30 days after surgery

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后其他并发症

指标类型:

次要指标

Outcome:

Other postoperative complications

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后平均住院日

指标类型:

次要指标

Outcome:

Mean postoperative hospital stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院费用

指标类型:

次要指标

Outcome:

hospitalization expenses

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

满意度

指标类型:

次要指标

Outcome:

satisfaction

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采取电脑生成随机序列法,对应所组成的随机数字序列的所有随机数字指定为试验组或对照组并记录在案.确定随机数字的分组必须由专人执行.

Randomization Procedure (please state who generates the random number sequence and by what method):

a random number sequence will be generated with computer and recorded by specialist.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过中国临床试验注册中心平台数据库

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

via Chinese Clinical Trial Registry database

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form,CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2020-10-04 23:53:04